Form 4: National Health Investors CFO John L. Spaid Reports Stock Transaction

CFO John L. Spaid of National Health Investors Inc. reports the disposition of 267 shares of common stock for tax settlement purposes on February 23, 2025.

Summary

• On February 23, 2025, John L. Spaid, CFO/EVP Finance of National Health Investors Inc., reported a transaction involving the company's common stock.
• The transaction involved the disposition of 267 shares at a price of $68.96 per share.
• This disposition was for the settlement of taxes upon the vesting of restricted shares.
• Following the transaction, Spaid directly owns 38,182.6372 shares of National Health Investors Inc.
• Spaid also holds options to buy 8,500 shares each from grants in 2023 and 2024 at strike prices of $54.73 and $57.76 respectively.

Sentiment

Score: 5

Explanation: This is a neutral report of a routine stock transaction by an executive. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is common in the real estate investment trust (REIT) sector, particularly among companies focused on healthcare properties like National Health Investors.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their insiders.
• The details provided are consistent with typical disclosures, including transaction dates, share amounts, and prices.
• Similar filings can be observed for executives at comparable REITs such as Welltower (WELL), Ventas (VTR), and Healthpeak Properties (PEAK).

Stakeholder Impact

• The transaction has a minimal direct impact on shareholders, as it involves a small number of shares relative to the company's total outstanding shares.
• The disposition of shares for tax purposes is a common practice and does not necessarily reflect a change in the executive's confidence in the company.

Key Dates